ClinicalTrials.Veeva

Menu

Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness Assessment (ENS)

I

Institut Mutualiste Montsouris

Status and phase

Unknown
Phase 3

Conditions

Polyneuropathy, Critical Illness

Treatments

Device: Neuromuscular electrical stimulation
Device: Sham control

Study type

Interventional

Funder types

Other

Identifiers

NCT02706587
REA 01-2014

Details and patient eligibility

About

The purpose of this study is to determine whether early neuromuscular electrical stimulation is effective in the prevention of neuromuscular weakness in critical ill patients.

Full description

Randomized, controlled study of early electrical neurostimulation (vs sham) in critically ill patients.

Enrollment

102 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patient
  • Aged of 18 or more
  • With an intended ICU stay of at least 72 hours
  • Mechanically ventilated

Exclusion criteria

  • Age less than 18 years
  • Pregnant women
  • Preexisting neuromuscular disease
  • Patient bearing a pace maker or an implantable defibrillator.
  • Poly traumatism and/or leg fracture.
  • End stage disease

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

102 participants in 2 patient groups

Neuromuscular electrical stimulation
Experimental group
Description:
NEMS is delivered bilaterally to the quadriceps femoris muscle using a portable battery-powered stimulator (Rehab 400, Cefar Compex, France). The electrodes are placed on the motor points of vastus medialis and vastus lateralis muscles. Electrical stimuli of 45Hz (pulse width: 380 µseconds; 6 seconds on with 1.5 second rise time; and 0.75 seconds fall time.; 5 seconds off). The current is adjusted to ensure maximum tolerable muscle contraction The protocol is applied twice daily for 25 minutes, five days a week.
Treatment:
Device: Neuromuscular electrical stimulation
Sham Control
Sham Comparator group
Description:
No electrostimulation
Treatment:
Device: Sham control

Trial contacts and locations

1

Loading...

Central trial contact

Celine Menez, PT; Christian Lamer, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems